JDSU Shares Key Product Advancements at ECOC 2014

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
JDSU Shares Key Product Advancements at ECOC 2014

MILPITAS, CA--(Marketwired - Sep 19, 2014) - JDSU ( NASDAQ : JDSU ) today announced that it will highlight the latest solutions from its optical communications and network and service enablement portfolios during the European Conference on Optical Communications (ECOC) at the Palais des Festivals et des Congress de Cannes in Cannes, France from September 21-25, 2014.

At booth #451, JDSU will demonstrate its latest offerings and important product advancements:

1.5 W Tunable SFP+ Transceiver. JDSU's Tunable SFP+ solutions allow network operators to flexibly switch from one wavelength to another to optimize network performance and drive greater density and efficiency. JDSU has already released a 1.7W version to volume manufacturing that is fully MSA compliant. The company has also demonstrated less than 1.3 W power dissipation at 70 C case temperature to guarantee less than 1.5W at end of life and is now moving this product into the sampling phase. The 1.5 W Tunable SFP+ transceiver will be released into volume manufacturing in Q1 2015, further extending JDSU's leadership in tunable products.

Second-Generation TrueFlex® Twin 1x9 and 1x20 WSS . JDSU introduced its second generation of twin wavelength selective switch (WSS) products, including 1x9 and 1x20 WSS's with dramatically reduced footprint and low-profile packages enabling single-slot linecard solutions that are ideal for metro and long-haul route-and-select ROADM configurations and for metro 2-degree ROADMs (reconfigurable optical add-drop multiplexer) with 8 port colorless add/drop capabilities. Two independently-switched WSS's are integrated within a single compact package with full flex-spectrum capabilities and the TrueFlex feature set, including intrachannel attenuation equalization.

TrueFlex Route & Select Super Transport Blade. The densest and most integrated linecard solution available to support next-generation ROADMs and software defined networks (SDN) within the metro and long haul optical networks, this new product integrates JDSU's second generation TrueFlex Twin 1x9 or 1x20 WSS, multiple optical channel monitors (OCM), switchable-gain preamp Erbium doped fiber amplifier (EDFA), and a variable gain postamp EDFA onto a single-slot linecard. JDSU currently has custom development programs underway with multiple customers.

ERGO laser. The JDSU pulse-generating laser built with SESAM® technology delivers exceptionally low jitter ( < 100fs), clean Gaussian picosecond pulses with high coherence and high repetition rate (up to 25GHz). The laser is a hands-free, turnkey solution.

ONT 100G with CFP2, QSFP28 and MLG. The JDSU ONT 100G test solution fully supports and validates third-generation 100G pluggable optics, including CFP4 and QSFP28, that are the pluggable modules essential to enable low cost deployment of 100G. The addition of the new MLG application helps to ensure that advanced module features can be brought to market quickly with a solution that combines physical layer and protocol support in one seamless application.

T-BERD/MTS-5800 with OTDR. The world's smallest dual-port 10G test instrument that allows for simultaneous Ethernet and fiber characterization/troubleshooting to help network technicians install, turn up and manage networks.

MAP-220C . A compact, two-slot MAP-220C chassis that significantly reduces the physical test station footprint and overhead costs as optical transponder and subsystem test stations are retooled for 100 and 400G. The MAP LightDirect platform supports the mOSW switch family as well as a broad range of modules that include switches, attenuators, power meters, and optical sources.

CSAM (100G Services Application Module). Leveraging next-generation CFP2 optics along with QSFP+ optics, users can install the CSAM in the T-BERD®/MTS-6000A test platform for the industry's smallest ultra-portable 100G tester.

Related Events Attendees are invited to three ECOC sessions that include JDSU experts:

About JDSU JDSU ( NASDAQ : JDSU ) innovates and collaborates with customers to build and operate the highest-performing and highest-value networks in the world. Our diverse technology portfolio also fights counterfeiting and enables high-powered commercial lasers for a range of applications. Learn more about JDSU at www.jdsu.com and follow us on JDSU Perspectives , Twitter , Facebook and LinkedIn.

Contacts Press: Bernie Tylor 240-404-1913 bernie.tylor@jdsu.com Investors: Bill Ong 408-546-4521 bill.ong@jdsu.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

M&A Source's 2026 Conference Tackles Deal-Making Drama

Updated Category News Views 130

High Stakes and Deep Insights Await in Houston Cracking the nut of lower-middle market transactions ain’t a walk in the park. M&A Source®'s Fall 2026 Conference is gearing up to address the very dramas that lurk behind the scenes. Kicking off November 2-4 at the opulent JW Marriott in Houston, Texas, the event is looking to assemble a heavyweight lineup of...

Continue Reading
Endava Faces Class Action: Investors Eye Their Next Move

Updated Category News Views 0

A Mess That Investors Can't Ignore If you're holding onto Endava plc shares, you've probably felt that gut-punch lately. Yeah, things are getting heated with a class action lawsuit alleging the company played fast and loose with its accounting practices. The complaint's about some shady dealings that may have thrown off investors' perceptions. The Core Allegations This...

Continue Reading
Astellas and Audax Forge $1.34B Immuno-Oncology Deal

Updated Category News Views 36

Big Moves in Immuno-Oncology: Astellas' Latest Bet You hear 'immuno-oncology,' you think breakthrough, right? Well, friends, that's what Astellas and Audax Biosciences are shooting for with their fresh handshake over DAX-044. On October 27, 2026, in Tokyo and Melbourne, the two outfits announced they're joining forces to bring this novel immunotherapy to the table. It's...

Continue Reading
OneQode & AdaniConneX Forge AI Path in India

Updated Category News Views 17

A Major Step Forward in AI Infrastructure When two heavyweights clash, you better believe folks are paying attention. OneQode’s deal with AdaniConneX is like a shot across the bow in the AI infrastructure arena. They’re not just dipping a toe in India’s tech waters; they’re diving headfirst with 14 MW of data center muscle right there in Siruseri Sipcot, Chennai....

Continue Reading
Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 48

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Brightstar's Cash Pop Shakes Up Illinois Lottery Scene

Updated Category News Views 63

A New Twist in Illinois: Cash Pop's Arrival Here's something fresh off the press: the Illinois Lottery is now on the ride with Brightstar's Cash Pop. This patented game isn't just another number pick—it's an engaging draw-based game featuring hourly draws with price tags of $1, $2, $5, and $10. It's like clockwork, and trust me, it's more than just the usual spin....

Continue Reading
Etisalat Surges: Net Profit Soars 46% Amid Growth

Updated Category News Views 91

Etisalat's Stellar Performance: A Deeper Dive When a company like Etisalat drops news of a whopping 46% increase in net profit year-over-year, you sit up and pay attention. Those numbers aren’t just a flash in the pan; they're the result of some serious strategic maneuvers and ripe market conditions. Etisalat isn't resting on its laurels, and their latest financials...

Continue Reading
Amgen Declares Q4 Dividend Amidst Broad Horizons

Updated Category News Views 16

Amgen's Steady Dividend: A Testament to Stability Diving into the mess that is today's biotech market, Amgen (NASDAQ:AMGN) stands out like a beacon of stability with its recent dividend announcement. The Board's decision to dole out a $2.52 per share dividend for the fourth quarter of 2026 showcases confidence amidst both promising ventures and looming uncertainties....

Continue Reading
2026 World Laureates Forum Drives Science Forward

Updated Category News Views 78

A Meeting of Great Minds in Shanghai Alright, listen up. Shanghai's gearing up to be the nerve center for the 2026 World Laureates Forum (WLF), and it's seething with potential. This ain't your regular science fair; it's a lion's den of brainpower set to crack open the future of science and tech. With the heavy-hitters like Nobel and Turing laureates on the docket, you're...

Continue Reading
Mercado González Opens, Integrates Mexican Culture

Updated Category News Views 27

Dive into Mercado González's Cultural Opening Over in La Habra, Northgate González Market has just flung open the doors to its latest masterpiece: Mercado González. Picture this, a place where the mundanity of grocery shopping melds with a vibrant fiesta of Mexican cuisine, artisanry, and cultural vibes. They transformed an older store into something that commands not...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Exelon's Earnings: Insights and Future Potential

Updated Category News Views 142

Understanding Exelon's Upcoming Earnings Report Exelon Corporation (NASDAQ: EXC) is preparing to reveal its quarterly earnings in the near future. Investors are keenly awaiting the results, as they want insights into the company’s performance and projections for the following period. Analysts predict that Exelon will report an earnings per share (EPS) of $0.39,...

Continue Reading
Vallourec Invites Warrant Holders to General Meeting

Updated Category News Views 157

Vallourec Invites Warrant Holders to General Meeting Vallourec has announced a significant upcoming event for its warrant holders, also known as BSA. This meeting is set to take place soon, providing an opportunity for holders to engage with the company's future decisions. Details of the Meeting The general meeting will occur at the Vallourec headquarters, where the...

Continue Reading
Investigation Initiated for Molina Healthcare Investors Following Financial Reports

Updated Category News Views 246

Pomerantz LLP Begins Investigation on Behalf of Molina Investors Pomerantz LLP has embarked on an investigation focusing on the interests of investors in Molina Healthcare, Inc. (NYSE: MOH). This inquiry aims to ascertain whether Molina and certain executives may have been involved in any unlawful activities related to securities fraud. Key Financial Findings and Investor...

Continue Reading
How SymphonyAI's Insights Drive E-commerce Growth in Grocery

Updated Category News Views 159

Unlocking E-commerce Potential in Grocery Retail In a transformative announcement, SymphonyAI, a leader in predictive and generative AI SaaS products for enterprises, has unveiled groundbreaking insights from its annual grocery e-commerce study. This research indicates a noteworthy 8% growth opportunity for retailers leveraging AI-driven strategies in their connected...

Continue Reading
Exploring the Impact of Honda and Nissan's Potential Merger

Updated Category News Views 408

Honda and Nissan's Strategic Talks Honda (NYSE:HMC) and Nissan (OTC:NSANY) have entered discussions that may lead to a potential merger, a significant move reflecting the shifting landscape of Japan's automotive industry. As these two giants explore deeper ties, it marks a notable strategy to face the competition posed by Tesla and various Chinese car manufacturers....

Continue Reading